President & Chief Executive Officer
Neil Gordon is President and Founder of Early Warning Inc, a nanotechnology spin-off company from NASA’s Ames Research Center. He is responsible for leading the business and technical direction of the world’s first pathogen sensor that automatically collects samples and simultaneously measures the concentration of a suite of pathogenic bacteria, viruses and parasites in 3 hours without a Biosafety lab or technician.
Neil is a technology business executive with a 25-year track record in starting-up high tech entities and commercializing first-of-a-kind technologies. In 2000 Neil became one of the nanotechnology sector’s first business consultants and has worked on over 20 nanotechnology commercialization projects worldwide, including evaluating diverse nanodevices and nanofabrication techniques for the Taiwan Government’s national lab ITRI, setting up a high throughput NanoImprint Lithography Prototyping Center for the Canadian Government’s national lab NRC, developing a nanomedicine taxonomy for the Canadian Institutes of Health Research, and working with various nanotechnology companies and venture capitalists. Neil also co-founded the Canadian NanoBusiness Alliance and was head of commercialization for CANEUS, a NASA-led initiative to set Micro and Nano technology standards in the aerospace and defense industry. Neil has a Bachelor of Engineering degree from McGill University and a Masters in Business Administration from the University of Western Ontario.
Business Development Director
Garry Palmateer is Early Warning's Business Development Director and oversees new business activities and product applications.
Garry was previously the President of GAP EnviroMicrobial Services, a pathogen testing laboratory and subsidiary of Conestoga Rovers. Garry was a former Regional Microbiologist with the Ontario Ministry of the Environment. In this capacity, he worked on microbiological issues concerning water quality, primarily in the areas of drinking water, groundwater, wastewater treatment, and the impact of urban and agricultural pollutants on surface water, including recreational waters. Garry is experienced in microbial and chemical testing for drinking water, and has acted as a consultant and as an expert witness in various water contamination and outbreak situations, including an E.coli O157:H7 outbreak in Walkerton, Ontario where 7 people died and half of the town's 5,000 people were sickened, and a Cryptosporidium outbreak in North Battleford, Saskatchewan. Garry earned a Masters Degree in Microbiology from the University of Guelph and has acquired 35 years of experience related to drinking water treatment, distribution, and testing from both surface and groundwater sources.
Bruce Gale, Ph.D.
Chief Science Officer
Dr. Bruce Gale is Early Warning's Chief Science Officer and oversees the technological aspects of biodetection and microfluidics development. He has a PhD in bio-engineering and specializes in the development and commercialization of microfluidics and biosensing devices for environmental and medical applications.
Bruce is the Director of the Utah State Center of Excellence for Biomedical Microfluidics and an Associate Professor of Mechanical Engineering at the University of Utah. He has led the scientific activities for numerous companies including Wasatch Microfluidics and Espira. He has authored over 100 peer-reviewed publications in the area of microfluidics and has been issued 1 US patent and has 9 patents pending.